MC2 Therapeutics A/S

MC2 Therapeutics A/S (CVR number: 29526346) is a company from RUDERSDAL. The company recorded a gross profit of 26.4 mDKK in 2023. The operating profit was 1669.6 kDKK, while net earnings were -41.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -12.7 %, which can be considered poor and Return on Equity (ROE) was -121 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -84.3 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. MC2 Therapeutics A/S's liquidity measured by quick ratio was 3.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.